expert roundtables

Highlight Article: Predicting Progression of Lower-Risk MDS
Oncology

Highlight Article: Predicting Progression of Lower-Risk MDS

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies
Oncology

HR+/HER2- Breast Cancer and the Problem of Resistance to Endocrine Therapies

expert roundtables
By Susan Dent, MD; Matthew P. Goetz, MD; Joseph A. Sparano, MD, FACP, FASCO
Clinical Roundup: Vaccine-Preventable Morbidity and Mortality Among Adolescents
Infectious Diseases

Clinical Roundup: Vaccine-Preventable Morbidity and Mortality Among Adolescents

expert roundtables
By Robert W. Frenck Jr., MD; Gary S. Marshall, MD; Flor M. Muñoz, MD, MSc, FAAP
Oncology

Predictors of Long-term Survival in Endometrial Cancer

expert roundtables
By David Scott Miller, MD, FACOG, FACS; Alexander B. Olawaiye, MD, FRCOG, FACOG, FACS; Pamela T. Soliman, MD, MPH
Major Unmet Clinical Needs in Chronic Lymphocytic Leukemia
Oncology

Major Unmet Clinical Needs in Chronic Lymphocytic Leukemia

expert roundtables
By Jennifer R. Brown, MD, PhD; John C. Byrd, MD; Susan O’Brien, MD
Load More